Free Trial
CVE:SBM

Sirona Biochem (SBM) Stock Price, News & Analysis

Sirona Biochem logo
C$0.06 -0.01 (-7.69%)
As of 03/7/2025

About Sirona Biochem Stock (CVE:SBM)

Key Stats

Today's Range
C$0.06
C$0.06
50-Day Range
C$0.05
C$0.07
52-Week Range
C$0.02
C$0.10
Volume
182,010 shs
Average Volume
79,592 shs
Market Capitalization
C$15.41 million
P/E Ratio
N/A
Dividend Yield
1.50%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.

Remove Ads
Receive SBM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sirona Biochem and its competitors with MarketBeat's FREE daily newsletter.

SBM Stock News Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Sirona Biochem Corp (SBM)
See More Headlines

SBM Stock Analysis - Frequently Asked Questions

Sirona Biochem's stock was trading at C$0.06 on January 1st, 2025. Since then, SBM shares have increased by 0.0% and is now trading at C$0.06.
View the best growth stocks for 2025 here
.

Shares of SBM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sirona Biochem investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Apellis Pharmaceuticals (APLS), Athersys (ATHX), Iovance Biotherapeutics (IOVA), Neovasc (NVCN) and Sorrento Therapeutics (SRNE).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:SBM
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-2,670,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$683,768.00
Cash Flow
C$0.00 per share
Price / Cash Flow
35.00
Book Value
C($0.01) per share
Price / Book
-6.00

Miscellaneous

Free Float
N/A
Market Cap
C$15.41 million
Optionable
Not Optionable
Beta
-0.03
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (CVE:SBM) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners